Salazar A, Howells J
Centre for Research on Innovation and Competition, Manchester Federal School of Management, Technology, University of Manchester and UMIST.
World Hosp Health Serv. 2000;36(2):6-10, 44-5.
This paper explores the specific trend and challenges facing the pharmaceutical industry regarding the exploitation of Internet e-commerce technology and virtual organisation to develop and maintain competitive advantage. There are two important facets of the current trend. One is the rapid development of a complex network of alliances between the established pharmaceutical companies and the specialised biotechnology company start-ups. The other is the rapid growth of internet e-commerce companies dedicated to developing specialised technological platforms for acquiring and selling genetic and biochemical knowledge. The underlying challenge is how big pharmaceutical companies can emulate some of the innovation processes of smaller biotechnology company start-ups, and how they can appropriate and applied new technological knowledge on the development of new drugs. Pharmaceutical companies in order to retain competitive advantage need to continuously monitor all aspects of knowledge management with regard to the R&D and manufacturing process (as well as customer management and marketing). Technological change and organisational restructuring should be aimed at boosting the capacity of large firms to innovate rapidly.
本文探讨了制药行业在利用互联网电子商务技术和虚拟组织来发展和维持竞争优势方面所面临的具体趋势和挑战。当前趋势有两个重要方面。一是老牌制药公司与新兴的专业生物技术公司之间迅速发展出复杂的联盟网络。另一个是致力于开发用于获取和销售基因及生化知识的专业技术平台的互联网电子商务公司迅速增长。潜在的挑战在于大型制药公司如何效仿小型生物技术初创公司的一些创新流程,以及它们如何获取并应用有关新药开发的新技术知识。制药公司为保持竞争优势,需要持续监控研发和生产过程(以及客户管理和营销)中知识管理的各个方面。技术变革和组织架构调整应旨在提高大公司快速创新的能力。